Protara Therapeutics (FRA:1KPA) ROE % Adjusted to Book Value : -110.41% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Protara Therapeutics ROE % Adjusted to Book Value?

Protara Therapeutics's ROE % for the quarter that ended in Sep. 2024 was -50.79%. Protara Therapeutics's PB Ratio for the quarter that ended in Sep. 2024 was 0.46. Protara Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -110.41%.

Protara Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Protara Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protara Therapeutics ROE % Adjusted to Book Value Chart

Protara Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-25.75

-64.86

-173.20

-150.39

Protara Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-204.25	-179.48	-91.12	-105.79	-110.41

Competitive Comparison of Protara Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Protara Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protara Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Protara Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Protara Therapeutics's ROE % Adjusted to Book Value falls into.

Protara Therapeutics ROE % Adjusted to Book Value Calculation

Protara Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-46.62%	/	0.31
	=	-150.39%

Protara Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-50.79%	/	0.46
	=	-110.41%

Protara Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Protara Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Protara Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protara Therapeutics Inc (FRA:1KPA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

TARA:USA

Address

345 Park Avenue South, 3rd Floor, New York, NY, USA, 10010

Website

http://www.protaratx.com

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Protara Therapeutics Headlines

No Headlines